retatrutide phase 2 Trial of for Obesity Retatrutide Phase 1 Trials |
Description
In December 2025, Eli Lilly announced positive topline results from TRIUMPH-4 a 68-week Phase 3 trial in adults with obesity and knee osteoarthritis in which retatrutide delivered average weight loss of up to 71.2 lbs alongside substantial reductions in osteoarthritis pain

A bathroom counter drawer or a small organizer box in the kitchen works
Learn How GLPs and Peptides Can Help April 29th | 6:30 PM 8:00PM Location: Juventas Wellness: 835 E 18th Ave, Denver, CO 80218 Join us for Elevate Your Every Day , a thoughtfully curated wellness event designed to help you feel your bestinside and out

Where to Get Prescribed: Doctor vs

This suggests that tirzepatide may contribute more to blood sugar regulation and weight management

Recommended rotation strategy: Rotate between the three approved sites : abdomen, thighs, and upper arms Within each site, move the injection location by at least 2.5 cm (1 inch) from the previous injection Establish a systematic pattern for example, abdomen for week one, right thigh for week two, left thigh for week three, right arm for week four, then repeat Keep a written record or use a smartphone app to track injection sites and dates Avoid injecting within 5 cm (2 inches) of the navel, scars, moles, or the waistline Absorption considerations: Product information for GLP-1 medications indicates no clinically relevant differences in absorption between approved injection sites
